Marino Garcia
Vermogen: 6 M $ op 30-09-2026
Vermogen: 6 M $ op 30-09-2026
Mr. Marino Garcia is a President, Chief Executive Officer & Director at Dianthus Therapeutics, Inc. and a President, Chief Executive Officer & Director at Dianthus Therapeutics OpCo, Inc. He is on the Board of Directors at AgomAb Therapeutics NV, Dianthus Therapeutics, Inc. and Dianthus Therapeutics OpCo, Inc. Mr. Garcia was previously employed as a Senior VP-Corporate & Business Development by Zealand Pharma A/S, a Chief Strategy Officer & Executive Vice President by Synergy Pharmaceuticals, Inc., a Vice President-Business Development by Aptalis Pharma Canada,Inc., and a Vice President-US Commercial Operations by Aspreva Pharmaceuticals Corp.
He received his undergraduate degree from Concordia University and an MBA from Richard Ivey School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-08-2026 | 65.292 ( 0,2% ) | 6 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Algemeen Directeur | 11-09-2023 |
| AGOMAB THERAPEUTICS NV | Directeur/Bestuurslid | 11-09-2026 |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Algemeen Directeur | 01-11-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ZEALAND PHARMA A/S | Corporate Officer/Principal | 01-10-2021 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 30-09-2018 |
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | 13-03-2014 |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-01-2010 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Richard Ivey School of Business
Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgomAb Therapeutics NV
AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Health Technology |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau